Table 3 Bivariate analysis showing the association of selected clinicopathologic characteristics with patients’ death
| Â | Death | ||
|---|---|---|---|
| Â | Yes | No | p-value |
HR and HER2 status, n (%) | Â | Â | 0.0006 |
 HR+/ HER2- | 18 (3.7) | 465 (96.3) | |
 HR−/ HER2+ | 1(10.0) | 9(90.0) |  |
 HR+/ HER2+ | 5(12.0) | 35(88.0) |  |
 HR−/ HER2- | 10 (14.3) | 60 (85.7) |  |
Stage, n (%) | Â | Â | 0.0006 |
 0, 1 | 8 (3.0) | 263 (97.0) | |
 2 | 12 (5.6) | 204 (94.4) | |
 3, 4 | 15 (12.9) | 101 (87.1) | |
PTEN status | Â | Â | 0.0001 |
 PTEN-WT, n (%) | 8 (2.5) | 317 (97.5) |  |
 PTEN-L, n (%) | 26 (9.4) | 252 (90.6) | |